1.Atopic dermatitis in the elderly
Xibao ZHANG ; Liangjiao DONG ; Ruixian YE ; Huanyan LIU ; Qiying XIONG
Chinese Journal of Dermatology 2021;54(5):447-451
In recent years, the category of atopic dermatitis (AD) has been updated in domestic and foreign guidelines, and elderly AD has been added as a subtype. The pathogenesis of elderly AD is related to heredity, skin barrier dysfunction, immune dysregulation and lifestyle. Most elderly AD patients have atypical clinical symptoms, and misdiagnosis is very common. To fully understand the pathogenesis and clinical characteristics of elderly AD, and to formulate individualized diagnosis and treatment plans based on clinical characteristics, are particularly important for improving the quality of life of patients and reducing the burden of the disease.
2.The research progress of extracellularvesicles for drug delivery as natural nanocarriers
Huanyan ZHANG ; Xuefeng WANG ; Yongbin MA ; Li LI ; Yang SHU ; Yi WANG
Chinese Pharmacological Bulletin 2017;33(6):757-760
Phospholipid membrane vesicles from cells play key roles in cell communication, antigen presentation, and transmission of infectious agents.Extracellular vesicles(EVs) carry various proteins, mRNA, and microRNA(miRNA), like a truck to bring different molecular cargoes to remote cells.Furthermore, the encapsulated molecules by EVs can be prevented from being degraded by enzymes in body fluids, making EVs as a natural, novel drug delivery system.In this paper, we review the progress of EVs for biological application and drug delivery vehicles from the classification and composition, which provides a theoretical basis for seeking new drug delivery systems for the treatment of diseases.
3.Role of microRNAs in inflammatory skin diseases
Ruixian YE ; Rujun XUE ; Jingyao LIANG ; Huanyan LIU ; Qiying XIONG ; Liangjiao DONG ; Xibao ZHANG
Chinese Journal of Dermatology 2021;54(2):178-182
MicroRNAs (miRNAs) are a class of non-coding RNA molecules that regulate gene expression after transcription and participate in various pathophysiological processes in the skin. In recent years, it has been reported that changes in miRNA expression profiles are related to some inflammatory skin diseases. For example, miR-203, miR-146a and miR-21 are upregulated in psoriatic lesions, miR-155 and miR-146a are upregulated in atopic dermatitis lesions, miR-21, miR-223, miR-142-3p and miR142-5p are upregulated in allergic contact dermatitis lesions; however, miR-146a and miR-155 are downregulated in peripheral blood of patients with systemic lupus erythematosus, and miR-223 is downregulated in dermatomyositis lesions. This review summarizes relationships of miRNAs with the occurrence and development of some inflammatory skin diseases.
4.Research on multifunctional fitness monitor based on FFT and photoelectric sensor.
He TIAN ; Huanyan ZHU ; Yu ZHANG ; Xu ZHANG
Chinese Journal of Medical Instrumentation 2013;37(1):23-26
This paper proposes a multifunctional fitness monitor based on FFT and photoelectric sensor, which uses pulse-type and non-invasive detection method to complete the analysis of the human blood oxygen saturation and heart rate. The system collects the absorption of red and infrared light absorbed by fingertip, then by programmable gain amplifier and the Fast Fourier analysis, it extracts the amplitude, frequency of the AC signal. PIC24FJ128GA010 is used to complete the collection, automatic gain judgment and signal processing. Finally, the result is calibrated by pulse blood oxygen emulator. Furthermore, it realizes the pedometer function based on three axles acceleration sensors MMA7260, which enhances fitness monitor's usability and allows people to obtain dynamic physiological signs when exercising.
Equipment Design
;
Fourier Analysis
;
Humans
;
Monitoring, Physiologic
;
instrumentation
;
Oximetry
;
instrumentation
;
methods
5.Prognostic value of pretreatment 18F-FDG PET/CT SUVmax on stage I-Ⅱ extranodal nasal type natural killer/T-cell lymphoma
Yafei ZHANG ; Zhen WANG ; Lili LIN ; Xin ZHAO ; Kanfeng LIU ; Yunqi ZHU ; Huatao WANG ; Huanyan ZHU ; Kui ZHAO
Chinese Journal of Nuclear Medicine and Molecular Imaging 2018;38(9):602-604
Objective To investigate the prognostic value of pretreatment 18F-fluorodeoxyglucose (FDG) PET/CT imaging on extranodal nasal type natural killer/T-cell lymphoma (ENKTL).Methods Thirtyfive patients (20 males,15 females,average age 45 years) diagnosed as Ann Arbor stage Ⅰ-Ⅱ ENKTL from February 2013 to February 2016 were retrospectively analyzed.All patients were pathologically confirmed and underwent 18F-FDG PET/CT before treatment.The maximum standardized uptake value (SUVmax),international prognostic index score (IPI),serum lactate dehydrogenase (LDH),and immunohistochemical results were recorded.Patients were followed up for 2 years.The relationships between SUVmax,progression-free survival (PFS),pathological features and IPI were assessed using Fisher exact test.Results There were 18 ENKTL patients with progression,and 17 had no progression.Patients with SUVmax ≥ 12.2 had worse prognosis than those with SUVmax< 12.2 (P =0.001).There were correlations between SUVmax and Ki-67 (r=0.701,P=0.001),SUVmax and CD56 (r=0.393,P=0.032),SUVmax and IPI (r=0.787,P<0.01),respectively.It was also found that SUVmax,Ki-67,CD56 and IPI were related to PFS (all P<0.05).Conclusion SUVmax of 18F-FDG could be used as an important prognostic indicator for early ENKTL.
6.An improved preparing process for rivastigmine
Jiaquan WU ; Ping ZHOU ; Yang LIU ; Chuanming JIE ; Huanyan CAO ; Tao PENG ; Xiaohong LI ; Haijun ZHANG
Journal of China Pharmaceutical University 2015;46(4):421-425
An improved manufacturing process for rivastigmine(1)was developed by performing the condensation reaction of m-hydroxyacetophenone(4)with N-ethyl-N-methyl carbamoyl chloride, then Corey-Bakshi-Shibata(CBS)chiral reduction to(R)-3-(1-hydroxyethyl)phenyl ethyl(methyl)carbamate(2)and then mesylation with methanesulfonyl chloride and nucleophilic substitution with dimethylamine, respectively. To be successful, a crucial reductive process in the conversion of ketone(3)to chiralalcohol(2)had to be correctly understood and optimized via orthogonal experiment. The whole improved process was convenient for operation and purification, with completion of the synthesis of rivastigmine and an overall yield of 88%.
7.Correlation Between Ceftazidime-avibactam Blood Concentration and Efficacy in Critically Ill Patients and Influential Factors
Shurun AN ; Li LIAO ; Huanyan PAN ; Xiaoxuan YANG ; Wei ZHANG ; Xiaoliang CHENG ; Weihong GE ; Xuemei LUO ; Yujie ZHOU
Herald of Medicine 2024;43(8):1291-1295
Objective To evaluate the relationship between ceftazidime-avibactam(CAZ-AVI)blood concentrations and efficacy in critically ill patients and to investigate the factors influencing blood levels.Methods The CAZ-AVI trough concentrations(Cmin)were detected in 29 patients who received CAZ-AVI treatment for at least 48 hours.The clinical materials of the patients were collected together for retrospective analysis.Results The Cmin of ceftazidime(CAZ)and avibactam(AVI)were(50.95±5.17)and(7.52±0.96)mg·L-1 in the effective group and(31.16±7.03)and(5.37±1.32)mg·L-1 in the ineffective group,respectively.The Cmin of CAZ in the effective group was significantly higher than in the ineffective group(P<0.05),and there was no significant difference in AVI Cmin between the two groups(P>0.05).Spearman's correlation analysis showed that CAZ Cmin was positively correlated with clinical efficacy(P<0.05),and no correlation between AVI Cmin and clinical efficacy(P>0.05).The optimal CAZ Cmin threshold was 24.59 mg·L-1.Multiple linear regression analysis showed that age and creatinine clearance was significantly correlated with the Cmin of CAZ,and creatinine clearance was significantly correlated with AVI Cmin(P<0.05).Conclusions The Cmin of CAZ correlates with efficacy,and it may be more beneficial for clinical treatment to keep the concentration of CAZ-AVI always greater than the minimum inhibitory concentration during the dosing interval.The creatinine clearance should be fully considered when optimizing CAZ-AVI dosage in critically ill patients.